SCHEDULE 13D/A
SCHEDULE 13D/ASchedule 13D ownership disclosure
MBX Biosciences Inc
Common Stock, $0.0001 par value per share · CUSIP: 55287L101
Event date: 2025-08-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Frazier Life Sciences Public Fund, L.P.Reported CIK 0001863769
Shares: 1,103,920.00 · Class: 3.3%
- FHMLSP, L.P.Reported CIK 0001879466
Shares: 1,103,920.00 · Class: 3.3%
- FHMLSP, L.L.C.Reported CIK 0001879465
Shares: 1,103,920.00 · Class: 3.3%
- Frazier Life Sciences Public Overage Fund, L.P.Reported CIK 0001913804
Shares: 325,653.00 · Class: 1.0%
- FHMLSP Overage, L.P.Reported CIK 0001963247
Shares: 325,653.00 · Class: 1.0%
- FHMLSP Overage, L.L.C.Reported CIK 0001963248
Shares: 325,653.00 · Class: 1.0%
- Frazier Life Sciences X, L.P.Reported CIK 0001790879
Shares: 4,552,774.00 · Class: 13.6%
- FHMLS X, L.P.Reported CIK 0001790880
Shares: 4,552,774.00 · Class: 13.6%
- FHMLS X, L.L.C.Reported CIK 0001790811
Shares: 4,552,774.00 · Class: 13.6%
- Frazier Life Sciences XI, L.P.Reported CIK 0001911592
Shares: 3,000.00 · Class: 0.0%
- FHMLS XI, L.P.Reported CIK 0001911580
Shares: 3,000.00 · Class: 0.0%
- FHMLS XI, L.L.C.Reported CIK 0001911623
Shares: 3,000.00 · Class: 0.0%
- James N. TopperReported CIK 0001341382
Shares: 4,552,774.00 · Class: 13.6%
- Patrick J. HeronReported CIK 0001365617
Shares: 4,557,097.00 · Class: 13.6%
- Albert ChaReported CIK 0001397906
Shares: 0.00 · Class: 0.0%
- James BrushReported CIK 0001865123
Shares: 0.00 · Class: 0.0%
- Daniel EstesReported CIK 0001702527
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-022503
- Form type
- SCHEDULE 13D/A
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Aug 20, 2025
- Reporting period
- Aug 18, 2025
- Description
- Schedule 13D beneficial ownership